Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: Final results of a randomized clinical trial

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 1, 2005, Pages 119-128

  Haffty, Bruce G ^a   Wilson, Lynn D ^a   Son, Yung H ^a   Cho, Edward I ^a   Papac, Rose J ^a   Fischer, Diana B ^a   Rockwell, Sara ^a   Sartorelli, Alan C ^a   Ross, Douglas A ^a   Sasaki, Clarence T ^a   Fischer, James J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Radiation therapy; Randomized trial; Squamous cell carcinoma of the head and neck

Indexed keywords

MITOMYCIN C (MC); PORFIRMOYCIN (POR); SQUAMOUS CELL CANCER OF THE HEAD AND NECK (SCCHN);

CHEMOTHERAPY; DISEASE CONTROL; HEMOGLOBIN; PATIENT MONITORING; RADIATION; TOXICITY; TUMORS;

RADIOTHERAPY;

HEMOGLOBIN; MITOMYCIN C; PORFIROMYCIN;

ACUTE TOXICITY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOSE RESPONSE; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SKIN INFLAMMATION; SQUAMOUS CELL CARCINOMA; STANDARDIZATION; SURVIVAL RATE; THROMBOCYTOPENIA; TOXICITY; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LEUKOPENIA; MALE; MIDDLE AGED; MITOMYCIN; PORFIROMYCIN; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; STATISTICS, NONPARAMETRIC; THROMBOCYTOPENIA;

EID: 19944420798     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.07.730     Document Type: Article

References (61)

1. D.J. Adelstein, J.P. Saxton, P. Lavertu A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results Head Neck 19 1997 567 575
2. M. Al-Sarraf, M. LeBlanc, P.G. Giri Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310 1317
3. D.M. Brizel, M.E. Albers, S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804
4. G.P. Browman, C. Cripps, D.I. Hodson Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer J Clin Oncol 12 1994 2648 2653
5. G. Calais, M. Alfonsi, E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081 2086
6. B.G. Haffty, Y.H. Son, R. Papac Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale Mitomycin Randomized Trials J Clin Oncol 15 1997 268 276
7. M. Merlano, V. Vitale, R. Rosso Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy N Engl J Med 327 1992 1115 1121
8. F. Sanchiz, A. Milla, J. Torner Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer Int J Radiat Oncol Biol Phys 19 1990 1347 1350
9. T.G. Wendt, G.G. Grabenbauer, C.M. Rodel Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study J Clin Oncol 16 1998 1318 1324
10. N.K. Gupta, R. Swindell Concomitant methotrexate and radiotherapy in advanced head and neck cancer: 15-year follow-up of a randomized clinical trial Clin Oncol (R Coll Radiol) 13 2001 339 344
11. N.K. Gupta, R.C. Pointon, P.M. Wilkinson A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer Clin Radiol 38 1987 575 581
12. J.P. Pignon, J. Bourhis, C. Domenge Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 355 2000 949 955
13. D.J. Adelstein Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer Curr Opin Oncol 10 1998 213 218
14. K.K. Fu, T.L. Phillips, I.J. Silverberg Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial J Clin Oncol 5 1987 1410 1418
15. L. Smid, H. Lesnicar, B. Zakotnik Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer--preliminary report Int J Radiat Oncol Biol Phys 32 1995 769 775
16. B.G. Haffty Concurrent chemoradiation in the treatment of head and neck cancer Hematol Oncol Clin North Am 13 1999 719 742 vi-vii
17. J.M. Brown Hypoxic cytotoxic agents: A new approach to cancer chemotherapy Drug Resist Updat 3 2000 7 13
18. J.M. Brown Therapeutic targets in radiotherapy Int J Radiat Oncol Biol Phys 49 2001 319 326
19. J.M. Brown Tumor microenvironment and the response to anticancer therapy Cancer Biol Ther 1 2002 453 458
20. S. Rockwell Use of hypoxia-directed drugs in the therapy of solid tumors Semin Oncol 19 1992 29 40
21. S. Rockwell Oxygen delivery: Implications for the biology and therapy of solid tumors Oncol Res 9 1997 383 390
22. J.M. Brown SR 4233 (tirapazamine): A new anticancer drug exploiting hypoxia in solid tumours Br J Cancer 67 1993 1163 1170
23. W. Dobrowsky, J. Naude Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers Radiother Oncol 57 2000 119 124
24. B.G. Haffty, Y.H. Son, C.T. Sasaki Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials Int J Radiat Oncol Biol Phys 27 1993 241 250
25. B.G. Haffty, R. Hurley, L.J. Peters Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: Results of a randomized clinical trial Cancer J Sci Am 5 1999 341 347
26. J. Overgaard, H.S. Hansen, M. Overgaard A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85 Radiother Oncol 46 1998 135 146
27. J. Overgaard, M.R. Horsman Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers Semin Radiat Oncol 6 1996 10 21
28. A.C. Sartorelli, W.F. Hodnick, M.F. Belcourt Mitomycin C: A prototype bioreductive agent Oncol Res 6 1994 501 508
29. S. Rockwell, S.R. Keyes, A.C. Sartorelli Preclinical studies of porfiromycin as an adjunct to radiotherapy Radiat Res 116 1988 100 113
30. S.R. Keyes, R. Loomis, M.P. DiGiovanna Cytotoxicity and DNA crosslinks produced by mitomycin analogs in aerobic and hypoxic EMT6 cells Cancer Commun 3 1991 351 356
31. L.H. Baker, R.M. Izbicki, V.K. Vaitkevicius Phase II study of porfiromycin vs mitomycin-C utilizing acute intermittent schedules Med Pediatr Oncol 2 1976 207 213
32. S. Rockwell, C.S. Hughes Effects of mitomycin C and porfiromycin on exponentially growing and plateau phase cultures Cell Prolif 27 1994 153 163
33. S. Rockwell, C.S. Hughes, S.R. Keyes Porfiromycin as an adjunct to radiotherapy in young and old mice Exp Gerontol 28 1993 281 293
34. S. Rockwell, S.Y. Kim Cytotoxic potential of monoalkylation products between mitomycins and DNA: Studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines Oncol Res 7 1995 39 47
35. S.R. Keyes, S. Rockwell, K.A. Kennedy Distribution of porfiromycin in EMT6 solid tumors and normal tissues of BALB/c mice J Natl Cancer Inst 83 1991 632 637
36. B.G. Haffty, Y.H. Son, L.D. Wilson Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck Radiat Oncol Investig 5 1997 235 245
37. J.D. Cox, J. Stetz, T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
38. M. Schemper, T.L. Smith A note on quantifying follow-up in studies of failure time Controlled Clinical Trials 17 1996 343 346
39. E.L. Kaplan, P.L. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
40. R. Peto, J. Peto Asymptotically efficient rank invariant test procedures (with discussion) J Royal Stat Soc A 135 1972 185 206
41. R.A. Fisher Statistical methods for research workers 12th ed 1954 Hafner New York
42. D.J. Adelstein Integration of chemotherapy into the definitive management of squamous cell head and neck cancer Curr Oncol Rep 1 1999 97 98
43. M. Al-Sarraf Treatment of locally advanced head and neck cancer: Historical and critical review Cancer Control 9 2002 387 399
44. C.R. Bradford Predictive factors in head and neck cancer Hematol Oncol Clin North Am 13 1999 777 785
45. D.M. Brizel Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma Semin Radiat Oncol 8 1998 237 246
46. R. De Crevoisier, C. Domenge, P. Wibault Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma Cancer 91 2001 2071 2076
47. R.K. Davis Prognostic variables in head and neck cancer: Tumor site, stage, nodal status, differentiation, and immune status Otolaryngol Clin North Am 18 1985 411 419
48. G.E. Laramore, C.B. Scott, D.E. Schuller Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: A comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head-and-neck database Int J Radiat Oncol Biol Phys 27 1993 1011 1016
49. C.R. Leemans, R. Tiwari, J.J. Nauta Recurrence at the primary site in head-and-neck cancer and the significance of neck lymph node metastases as a prognostic factor Cancer 73 1994 187 190
50. R.V. Mantravadi, E.M. Skolnik, R.E. Haas Patterns of cancer recurrence in the postoperatively irradiated neck Arch Otolaryngol 109 1983 753 756
51. W.M. Mendenhall, S.P. Stringer, R.J. Amdur Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue? J Clin Oncol 18 2000 35 42
52. J. Overgaard, H.S. Hansen, K. Jorgensen Primary radiotherapy of larynx and pharynx carcinoma: An analysis of some factors influencing local control and survival Int J Radiat Oncol Biol Phys 12 1986 515 521
53. R.J. Papac Distant metastases from head-and-neck cancer Cancer 53 1984 342 345
54. J.F. Piccirillo Impact of comorbidity and symptoms on the prognosis of patients with oral carcinoma [letter; comment] Arch Otolaryngol Head Neck Surg 126 2000 1086 1088
55. A.J. Munro An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer Br J Cancer 71 1995 83 91
56. J.M. Brown, B.G. Siim Hypoxia-specific cytotoxins in cancer therapy Semin Radiat Oncol 6 1996 22 36
57. W. Dobrowsky, J. Naude, E. Dobrowsky Mitomycin C (MMC) and unconventional fractionation (V-CHART) in advanced head and neck cancer Acta Oncol 34 1995 270 272
58. B.G. Haffty, R.A. Hurley, L.G. Peters Carcinoma of the larynx treated with hypofractionated radiation and hyperbaric oxygen: Long-term tumor control and complications Int J Radiat Oncol Biol Phys 45 1999 13 20
59. J.B. Weissberg, Y.H. Son, R.J. Papac Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head-and-neck cancer Int J Radiat Oncol Biol Phys 17 1989 3 9
60. B. Zakotnik, L. Smid, M. Budihna Concomitant radiotherapy with mitomycin C and bleomycin compared with radiotherapy alone in inoperable head-and-neck cancer: Final report Int J Radiat Oncol Biol Phys 41 1998 1121 1127
61. A.C. Sartorelli Therapeutic attack of hypoxic cells of solid tumors: Presidential address Cancer Res 48 1988 775 778